Core Points - The company announced the unfortunate passing of its director and vice president, Liu Zhonghua, due to sudden illness on September 12, 2025, expressing deep condolences and respect for his contributions [1][2] - Liu Zhonghua held 2,152,512 shares of the company, representing 2.57% of the total share capital, and the company will follow legal procedures regarding his shares [2] - Following his death, the board of directors will reduce from 9 to 8 members, which does not affect the normal operation but is below the number stipulated in the company's articles of association, prompting a need for a board member replacement [2]

Core Points - Liu Zhonghua, the Vice President of Shuoshi Biotechnology, passed away due to sudden illness on September 12, 2025, at the age of 56 [1] - Liu was a core founder of the company and made significant contributions to its establishment and growth, particularly in the fields of infectious disease testing, cancer screening, and maternal and child health diagnostics [1][2] - Liu held a Ph.D. from Xi'an Jiaotong University and was an expert in molecular biology, with a career that included research at the Chinese Academy of Medical Sciences and collaborations in the U.S. [1] Company Impact - Following Liu's death, the board of directors of Shuoshi Biotechnology decreased from 9 to 8 members, which does not affect the normal operation of the board but is below the number stipulated in the company's articles of association [2] - The company will conduct a board member replacement process in accordance with the Company Law of the People's Republic of China and its articles of association [2] - Liu directly held 2.57% of the company's total shares, amounting to 2.1525 million shares, which will be handled according to relevant laws and regulations [2]

Core Points - Liu Zhonghua, the Vice President of Shuoshi Biotechnology, passed away due to sudden illness on September 12, 2025, at the age of 56 [2] - Liu was a core founder of the company and made significant contributions to its establishment and growth, particularly in the fields of infectious disease testing, cancer screening, and maternal and child health diagnostics [4][5] - Liu held a Ph.D. from Xi'an Jiaotong University and was an expert in molecular biology, with a career that included research at the Chinese Academy of Medical Sciences and collaborations in the U.S. [4] - Following Liu's death, the board of directors of Shuoshi Biotechnology decreased from 9 to 8 members, which does not affect the normal operation of the board but is below the number stipulated in the company's articles of association [5]